Genetic and Environmental Risk Factors for Exfoliation Syndrome and Glaucoma

剥脱性综合征和青光眼的遗传和环境风险因素

基本信息

  • 批准号:
    8726405
  • 负责人:
  • 金额:
    $ 68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-01 至 2016-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Exfoliation syndrome (ES) is a common condition characterized by deposition of a heterogeneous mix of macromolecules throughout the anterior segment of the eye. The factors that cause this material to accumulate in ES remain unknown. ES is a public health problem, because it is a risk factor for high-tension open-angle glaucoma, pre-mature cataract formation, and increased risk of complications during cataract surgery. Previous studies suggest that exfoliation syndrome and the related glaucoma are genetically complex, and one gene, LOXL1, has been identified as a major genetic risk factor. LOXL1 gene variants are found in up to 98% of affected patients; however, these same variants are also present in up to 80% of unaffected individuals, indicating that additional genetic and/or environmental factors are necessary for disease development. Further evidence that LOXL1 is necessary but not sufficient for the disease comes from our preliminary studies of the LOXL1 null mouse that identified some, but not all the phenotypic features of the condition. To identify additional genetic and environmental factors contributing to exfoliation syndrome and exfoliation glaucoma, we have formed a collaborative consortium contributing over 2300 exfoliation cases and 2300 controls. Whole genome genotyping has already been completed in 650 cases and 2250 controls, and over 1000 cases have detailed environmental exposures. We will perform a single stage GWAS to identify additional genetic markers associated with exfoliation syndrome, and will also investigate associations between ES and environmental exposures including factors that influence homocysteine levels the effect of residence in northern latitude. Newly discovered genetic and environmental risk factors will be analyzed for gene- environment and gene-gene interactions.
描述(由申请人提供):去角质综合征(ES)是一种常见的疾病,其特征是在整个眼前部分中大分子的异质混合物沉积。导致该材料积聚在ES中的因素仍然未知。 ES是一个公共卫生问题,因为它是高张力开开角糖瘤,成熟的白内障形成以及白内障手术中并发症风险增加的危险因素。先前的研究表明,去角质综合征和相关的青光眼在遗传上是复杂的,而一个基因LOXL1已被鉴定为主要的遗传危险因素。在多达98%的受影响的患者中发现LOXL1基因变体。但是,这些相同的变体也有多达80%的未受影响的个体存在,这表明其他遗传和/或环境因素对于疾病的发展是必需的。进一步的证据表明,LOXL1是必要的,但对于该疾病不足,这是我们对LOXL1 NULL小鼠的初步研究,该研究确定了某些疾病的某些表型特征。为了确定导致去角质综合征和去角色青光眼的其他遗传和环境因素,我们形成了一个合作联盟,贡献了2300多种剥落病例和2300个控制。整个基因组基因分型已经在650例和2250例控制中完成,超过1000例具有详细的环境暴露。我们将执行一个单阶段的GWA,以识别与去角质综合征相关的其他遗传标记,还将研究ES与环境暴露之间的关联,包括影响同型半胱氨酸水平的因素,北纬地区的住所影响。新发现的遗传和环境风险因素将分析基因环境和基因 - 基因相互作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Janey L Wiggs其他文献

Janey L Wiggs的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Janey L Wiggs', 18)}}的其他基金

Defining early-onset glaucomagenetic etiologies
定义早发性青光眼病因
  • 批准号:
    10249270
  • 财政年份:
    2020
  • 资助金额:
    $ 68万
  • 项目类别:
Defining early-onset glaucomagenetic etiologies
定义早发性青光眼病因
  • 批准号:
    10448282
  • 财政年份:
    2020
  • 资助金额:
    $ 68万
  • 项目类别:
Defining early-onset glaucomagenetic etiologies
定义早发性青光眼病因
  • 批准号:
    10662296
  • 财政年份:
    2020
  • 资助金额:
    $ 68万
  • 项目类别:
Defining early-onset glaucomagenetic etiologies
定义早发性青光眼病因
  • 批准号:
    10034199
  • 财政年份:
    2020
  • 资助金额:
    $ 68万
  • 项目类别:
Genetic Risk Factors for Central Vision Loss in Glaucoma
青光眼中央视力丧失的遗传风险因素
  • 批准号:
    8622199
  • 财政年份:
    2013
  • 资助金额:
    $ 68万
  • 项目类别:
Genetic Risk Factors for Central Vision Loss in Glaucoma
青光眼中央视力丧失的遗传风险因素
  • 批准号:
    8510304
  • 财政年份:
    2013
  • 资助金额:
    $ 68万
  • 项目类别:
NEIGHBORHOOD Consortium for POAG Genetics
POAG 遗传学 NEIGHBORHOOD 联盟
  • 批准号:
    9148181
  • 财政年份:
    2012
  • 资助金额:
    $ 68万
  • 项目类别:
NEIGHBORHOOD Consortium for POAG Genetics
POAG 遗传学 NEIGHBORHOOD 联盟
  • 批准号:
    9173545
  • 财政年份:
    2012
  • 资助金额:
    $ 68万
  • 项目类别:
The NEIGHBORHOOD: POAG Heritable Overall Operational Database
NEIGHBORHOOD:POAG 可遗传整体运营数据库
  • 批准号:
    8265099
  • 财政年份:
    2012
  • 资助金额:
    $ 68万
  • 项目类别:
The NEIGHBORHOOD: POAG Heritable Overall Operational Database
NEIGHBORHOOD:POAG 可遗传整体运营数据库
  • 批准号:
    8511668
  • 财政年份:
    2012
  • 资助金额:
    $ 68万
  • 项目类别:

相似海外基金

Novel ocular imaging and molecular analysis of anterior eye segment for glaucoma
青光眼眼前节的新型眼部成像和分子分析
  • 批准号:
    10607885
  • 财政年份:
    2023
  • 资助金额:
    $ 68万
  • 项目类别:
Novel hybrid molecule with both IOP lowering and neuroprotective effects for treatment of glaucoma
具有降低眼压和神经保护作用的新型混合分子可用于治疗青光眼
  • 批准号:
    10477236
  • 财政年份:
    2020
  • 资助金额:
    $ 68万
  • 项目类别:
Novel hybrid molecule with both IOP lowering and neuroprotective effects for treatment of glaucoma
具有降低眼压和神经保护作用的新型混合分子可用于治疗青光眼
  • 批准号:
    10684092
  • 财政年份:
    2020
  • 资助金额:
    $ 68万
  • 项目类别:
Ophthalmic Time-resolved Confocal Scanning Microfluorometer
眼科时间分辨共焦扫描显微荧光计
  • 批准号:
    10080180
  • 财政年份:
    2020
  • 资助金额:
    $ 68万
  • 项目类别:
Novel hybrid molecule with both IOP lowering and neuroprotective effects for treatment of glaucoma
具有降低眼压和神经保护作用的新型混合分子可用于治疗青光眼
  • 批准号:
    10226000
  • 财政年份:
    2020
  • 资助金额:
    $ 68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了